Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Michael Grela Elected President of the Society for Health Communication

July 6, 2022 | evokekyne 

February 8, 2022 – Michael Grela, Evoke KYNE’s EVP, Head of Reputation and Social Impact, has been elected President of the Society for Health Communication, a member-driven organization working to advance the science of health communication by advocating for the use of evidence-based communication strategies that inform, empower and motivate individuals and communities to lead healthier lives. As President, Grela will be responsible for overseeing the Society’s newly expanded Steering Committee and partnering with Executive Director Diane Brodalski and Member-at-Large Shelly Spöeth to set and achieve its member engagement, diversity, equity and inclusion, and overall growth goals. He has been a member of its Steering Committee since 2017 and most recently served as its Vice President, 2020-2021.

“It has been a pleasure serving with Michael over the past two years and I’m thrilled to pass the torch to him as we as we continue on our journey of building a stronger, more connected field,” said Terry Savage, Vice President, Westat, and 2020-2021 Society President.

At Evoke KYNE, Michael oversees client engagements in health equity, reputation and social impact as well as the agency’s own social impact programs, external communications, awards and publications, thought leadership and related employee engagement.

“Evoke KYNE congratulates Michael on this honor and recognizes his impressive contributions to the field of health communication and our industry,” said Maureen Byrne, Partner, Evoke KYNE. “The Society’s work has never been more critical and this milestone showcases our collective and enduring belief that communication is a powerful health intervention that can help improve and save lives.”

You can learn more by visiting the Society website.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...